Hims & Hers (NASDAQ: HIMS) stock has done well since the company went public a few years ago. It has soared by over 193% in ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Alright, so you’ve heard of Ozempic, right? The “magic” weight loss drug that’s everywhere—TikTok, the news, probably y ...

If you're looking to make your hair grow faster, try Viviscal, the most-loved hair supplement by Cosmo readers, which is ...

Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer ...

Snag Vegamour's mega-popular formula for just $45: 'I have virtually no visibly bald areas,' says one fan.

HIMS is growing at a complete breakneck pace. The main question that looms over its prospects is this. How sustainable are its growth rates? And my answer is that this level of growth is not ...

Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...

If you’re dealing with male pattern baldness, there’s a good chance you’ve heard of or use finasteride. You also may have ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than ...